InsidersTradesSigma
광동제약 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 광동제약 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Food & Beverage sector, 광동제약 has published 41 insider filings. Market capitalisation: €316.8bn. The latest transaction was disclosed on 14 April 2026 (Other). Among the most active insiders: 최성원. Every trade is openly available.
41
Insider Decl.
0
Thresholds
€76,292
5 ops.
Buy Volume
·
0 ops.
Sell Volume
16Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 13,413 of 26,282 companies
51.3
score / 100
Value75
Quality27
FCF yld19%
Earn yld7.0%
EV/EBITDA10.1x
ROE3.3%
Gross mgn18%
Net mgn1.3%
Debt/EBITDA5.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 14 April 2026
Declarations41 total
25 of 41 declarations